Precipio, Inc.(PRPO)Earnings, Financials & Key Ratios
PRPO•NASDAQ
$25.26
Price updated Jul 6, 2026
AboutPrecipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust genetic diagnostic panels; ICE-COLD PCR, a proprietary and patented specimen technology that increases the sensitivity of molecular based tests; and COVID-19 antibody tests. It sells ICE-COLD-PCR technology kits to bio-pharma customers. Precipio, Inc. has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment. The company is based in New Haven, Connecticut.Show more
- Revenue$16M+5.1%
- EBITDA-$3M+57.2%
- Net Income-$4M+26.7%
- EPS (Diluted)-2.93+35.0%
- Gross Margin47.35%+19.6%
- EBITDA Margin-16.93%+59.2%
- Operating Margin-26.41%+47.3%
- Net Margin-26.87%+30.2%
- ROE-32.35%+14.9%
PRPO Price & Volume
Precipio, Inc. (PRPO) stock price & volume — 10-year historical chart
Loading chart...
Persistent Operating Losses Obscure Diagnostic Growth Potential
Investment Thesis • Updated 2025Q3
VerdictNegative
Growth:Mixed
Profitability:Negative
Financial:Vulnerable
Cash Flow:Burning
Primary Risk:Imminent liquidity and dilution
Key Thesis Takeaways
- Precipio faces a challenging path to profitability as it struggles to scale its HemeScreen platform while managing significant operational overhead.
- The company's reliance on dilutive financing is underscored by a massive $103.3 million accumulated deficit and a precarious cash position of only $2.3 million as of 2025Q3.
- Investors should remain cautious, as the firm's inability to achieve consistent operating leverage suggests that the current business model may require further capital infusions to sustain ongoing diagnostic operations.
Verdict Logic
the company's precarious liquidity position, highlighted by a cash balance of only $2.3 million against persistent operating losses, suggests a high risk of further shareholder dilution.
PRPO Growth Metrics
Precipio, Inc. (PRPO) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-5.15%
5 Years38.55%
3 Years21.74%
TTM23.63%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM58.2%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM59.04%
Return on Capital
10 Years-90.11%
5 Years-48.2%
3 Years-45.65%
Last Year-30.46%
Peers Comparison
Key metrics vs top competitors for Precipio, Inc. (PRPO)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $25.26 | $44.1M | -8.62 | 5.05% | -26.87% | -32.35% | — | |
| $29.06 | $1.5B | -72.65 | 13.79% | -1.98% | -2.61% | — | |
| $1.66 | $515.6M | -0.91 | 3.89% | -80.34% | -488.45% | — | |
| $283.80 | $40.64B | -186.71 | 35.9% | -9.05% | -15.13% | — | |
| $104.91 | $20.02B | -95.37 | 17.69% | -6.4% | -8.66% | — | |
| $58.00 | $4.63B | 70.73 | 16.01% | 16.25% | 6.86% | — |
Compare PRPO vs Peers
Precipio, Inc. (PRPO) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Get notified when PRPO posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
PRPO Frequently Asked Questions
Precipio, Inc. (PRPO) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
What is Precipio, Inc.'s revenue?
Precipio, Inc. (PRPO) reported $21.5M in revenue for fiscal year 2024. This represents a 7% decrease from $23.0M in 1999.
How fast is Precipio, Inc. growing?
Precipio, Inc. (PRPO) grew revenue by 5.1% over the past year. This is steady growth.
Is PRPO profitable?
Precipio, Inc. (PRPO) reported a net loss of $1.3M for fiscal year 2024.
Dividend & Returns
What is PRPO's return on equity?
Precipio, Inc. (PRPO) has a return on equity (ROE) of -32.3%. Negative ROE indicates the company is unprofitable.
What is Precipio, Inc.'s free cash flow?
Precipio, Inc. (PRPO) generated $0.6M in free cash flow for fiscal year 2024. Positive FCF indicates the company can fund dividends, buybacks, or reinvestment.